Clinicians in the dark about potential harms of commonly prescribed beta blocker

Better understanding needed to stave off overdose deaths, warns HSIB Related items fromOnMedica Withdrawn valsartan meds not linked to short-term cancer risk Too few women take part in many CVD clinical trials Pharmacists could offer high-dose statins direct to patients Cannabinoids not recommended to treat cancer-related pain GPs defend practice on prescribing statins
Source: OnMedica Latest News - Category: UK Health Source Type: news